ESC 365 - The PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes.

ESC Professional Premium Access

The PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes.

Session: Basic and Translational Late-Breaking Science 2

Topic: Athlete´s Heart

Speaker: Assistant Professor G. Claessen (Hasselt, BE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Assistant Professor Guido Claessen

Heart Centre Hasselt, Hasselt (Belgium)

10 presentations

1 follower

3 more presentations in this session

CKD-510, A Non-hydroxamic Acid Hdac6 Inhibitor, For Treatment Of Atrial Fibrillation.

Speaker: Doctor B. Lee (Yongin, KR)

Ventricular Arrhythmic Risk Prediction in Low- and Moderate-risk Populations Using a Single-Lead ECG Heartbeat.

Speaker: Doctor J. Ramirez (Zaragoza, ES)

Precision approaches to defining susceptibility to atrial fibrillation determine risk of cardioembolic stroke.

Speaker: Doctor P. Gajendragadkar (Oxford, GB)

Access the full session

Basic and Translational Late-Breaking Science 2

Speakers: Assistant Professor G. Claessen, Doctor B. Lee, Doctor J. Ramirez, Doctor P. Gajendragadkar

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources